151 related articles for article (PubMed ID: 2209339)
1. Sulfonylureas. Why, which, and how?
Melander A; Lebovitz HE; Faber OK
Diabetes Care; 1990 Aug; 13 Suppl 3():18-25. PubMed ID: 2209339
[TBL] [Abstract][Full Text] [Related]
2. The place of sulfonylureas in the therapy for type 2 diabetes mellitus.
Del Prato S; Pulizzi N
Metabolism; 2006 May; 55(5 Suppl 1):S20-7. PubMed ID: 16631807
[TBL] [Abstract][Full Text] [Related]
3. Kinetics-effect relations of insulin-releasing drugs in patients with type 2 diabetes: brief overview.
Melander A
Diabetes; 2004 Dec; 53 Suppl 3():S151-5. PubMed ID: 15561903
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacology of sulfonylureas.
Melander A
Metabolism; 1987 Feb; 36(2 Suppl 1):12-6. PubMed ID: 3543616
[TBL] [Abstract][Full Text] [Related]
5. Rational use of sulfonylureas.
Davidson MB
Postgrad Med; 1992 Aug; 92(2):69-70, 73-6, 79-85. PubMed ID: 1495885
[TBL] [Abstract][Full Text] [Related]
6. Use of sulfonylurea agents in older diabetic patients.
Peters AL; Davidson MB
Clin Geriatr Med; 1990 Nov; 6(4):903-21. PubMed ID: 2224754
[TBL] [Abstract][Full Text] [Related]
7. Are sulfonylureas passé?
Green JB; Feinglos MN
Curr Diab Rep; 2006 Nov; 6(5):373-7. PubMed ID: 17076998
[TBL] [Abstract][Full Text] [Related]
8. Sulfonylureas in NIDDM.
Groop LC
Diabetes Care; 1992 Jun; 15(6):737-54. PubMed ID: 1600834
[TBL] [Abstract][Full Text] [Related]
9. [Successful treatment of severe sulfonylurea-induced hypoglycemia by the subcutaneous administration of octreotide in an elderly patient with diabetes: A case report].
Nakaya M; Oka R; Miyamoto S
Nihon Ronen Igakkai Zasshi; 2019; 56(3):336-342. PubMed ID: 31366755
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of sulfonylureas with insulin in type 2 diabetes mellitus.
Kabadi MU; Kabadi UM
Ann Pharmacother; 2003 Nov; 37(11):1572-6. PubMed ID: 14565810
[TBL] [Abstract][Full Text] [Related]
11. Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas.
Ragia G; Petridis I; Tavridou A; Christakidis D; Manolopoulos VG
Pharmacogenomics; 2009 Nov; 10(11):1781-7. PubMed ID: 19891554
[TBL] [Abstract][Full Text] [Related]
12. Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man.
Pfeifer MA; Halter JB; Judzewitsch RG; Beard JC; Best JD; Ward WK; Porte D
Diabetes Care; 1984; 7 Suppl 1():25-34. PubMed ID: 6376026
[TBL] [Abstract][Full Text] [Related]
13. Hypoglycemia-induced myocardial infarction: an unusual adverse effect of sulfonylureas.
Chang JH; Tseng CF; Wang JY
Int J Cardiol; 2007 Feb; 115(3):414-6. PubMed ID: 16787671
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive drug therapy and hypoglycemia in elderly diabetic patients treated with insulin and/or sulfonylureas. Gruppo Italiano di Farmacovigilanza nell'Anziano (GIFA).
Corsonello A; Pedone C; Corica F; Malara A; Carosella L; Sgadari A; Mauro VN; Ceruso D; Pahor M; Carbonin P
Eur J Epidemiol; 1999 Nov; 15(10):893-901. PubMed ID: 10669122
[TBL] [Abstract][Full Text] [Related]
15. Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus.
Ou SM; Shih CJ; Chao PW; Chu H; Kuo SC; Lee YJ; Wang SJ; Yang CY; Lin CC; Chen TJ; Tarng DC; Li SY; Chen YT
Ann Intern Med; 2015 Nov; 163(9):663-72. PubMed ID: 26457538
[TBL] [Abstract][Full Text] [Related]
16. Sulfonylurea drugs and insulin-independent diabetes mellitus.
Lebovitz HE; Feinglos MN
Compr Ther; 1979 Apr; 5(4):65-71. PubMed ID: 445991
[TBL] [Abstract][Full Text] [Related]
17. Oral hypoglycemic agents in type II diabetes mellitus.
Lubbos H; Miller JL; Rose LI
Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
[TBL] [Abstract][Full Text] [Related]
18. [Role of octreotide in the treatment of hypoglycemia induced by sulfonylureas].
Clerc D; Hugli O; Trueb L; Yersin B
Rev Med Suisse; 2008 Aug; 4(167):1764-7. PubMed ID: 18800755
[TBL] [Abstract][Full Text] [Related]
19. Role of sulfonylureas in non-insulin-dependent diabetes mellitus: Part II--"The cons".
Heine RJ
Horm Metab Res; 1996 Sep; 28(9):522-6. PubMed ID: 8911991
[TBL] [Abstract][Full Text] [Related]
20. Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.
Melander A; Bitzén PO; Faber O; Groop L
Drugs; 1989 Jan; 37(1):58-72. PubMed ID: 2651086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
